SV Health Investors

Venture capital firm based in London, UK

SV Health Investors Investments

SV Health Investors has invested in these startups.

Sitryx Therapeutics

Sitryx Therapeutics secures $39 million funding to develop disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by regulating cell metabolism, with new investor Oxford Science Enterprises joining a strong healthcare investor lineup. Read more

Enara Bio

Healthtech

Enara Bio secures a game-changing $32.5 million in Series B funding, setting the stage to revolutionize cancer therapy with its innovative Dark Antigen targets! Read more

Harness Therapeutics

Biotech

Cambridge-based biotech company, Harness Therapeutics, secures an impressive £4 million in additional funding to advance its lead programme in targeting Huntington's Disease, bringing their total raised to £17.6 million. Read more

Investments By Sector

SV Health Investors has invested in these sectors

Healthtech	66.7%
Biotech	33.3%

Venture Capital Investors

Connect with VC Investors from SV Health Investors

Kate Bingham

Alex Badamchi-Zadeh

Laurence Barker

Georgia Frost

Lennart Spindler

Charles Dunn

They Have Invested With SV Health Investors

Connect with investors related to SV Health Investors's network

Oxford Science Enterprises

Sofinnova Partners

Longwood Fund

M Ventures

Epidarex Capital

List of pre-seed

& seed VC firms

2025 Startupmag.co.uk © Kohdao Ltd. Unit 8B Raleigh Gardens, Brixton, London, SW2 1AD, UK.
Registration 06261702. Data Protection No: ZA891746.

SV Health Investors